Natural ligands of PPARgamma: are prostaglandin J(2) derivatives really playing the part? (Q34602968)

3 August 2017

1 reference

title

Natural ligands of PPARgamma: are prostaglandin J(2) derivatives really playing the part? (English)

1 reference

3 August 2017

Olivier Nosjean

1

1 reference

PubMed ID

11955950

3 August 2017

Jean A Boutin

series ordinal

2

1 reference

3 August 2017

1 July 2002

1 reference

3 August 2017

11

1 reference

inferred from page(s)

published in

Cellular Signalling

1 reference

3 August 2017

14

1 reference

3 August 2017

573-583

1 reference

3 August 2017

7

1 reference

A ligand of peroxisome proliferator-activated receptor gamma, retinoids, and prevention of preneoplastic mammary lesions

3 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900281-9

7 January 2021

Transactivation by retinoid X receptor-peroxisome proliferator-activated receptor gamma (PPARgamma) heterodimers: intermolecular synergy requires only the PPARgamma hormone-dependent activation function

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900281-9

7 January 2021

9-Deoxy-delta 9, delta 12-13,14-dihydroprostaglandin D2, a metabolite of prostaglandin D2 formed in human plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900281-9

7 January 2021

Formation of thiol conjugates of 9-deoxy-delta 9,delta 12(E)-prostaglandin D2 and delta 12(E)-prostaglandin D2.

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900281-9

7 January 2021

Activators of peroxisome proliferator-activated receptor-gamma (PPARgamma) inhibit inducible nitric oxide synthase expression but increase heme oxygenase-1 expression in rat glial cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900281-9

7 January 2021

Cyclopentenone prostaglandins suppress activation of microglia: down-regulation of inducible nitric-oxide synthase by 15-deoxy-Delta12,14-prostaglandin J2

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900281-9

7 January 2021

Prostaglandin J(2) inhibition of mesangial cell iNOS expression

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900281-9

7 January 2021

Peroxisome proliferator-activated receptor gamma agonists protect cerebellar granule cells from cytokine-induced apoptotic cell death by inhibition of inducible nitric oxide synthase

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900281-9

7 January 2021

Role of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma) and its natural ligand 15-deoxy-Delta12, 14-prostaglandin J2 in the regulation of microglial functions

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900281-9

7 January 2021

Activation of peroxisome proliferator-activated receptor gamma does not inhibit IL-6 or TNF-alpha responses of macrophages to lipopolysaccharide in vitro or in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900281-9

7 January 2021

Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900281-9

7 January 2021

Regulation of the Hedgehog and Wingless signalling pathways by the F-box/WD40-repeat protein Slimb

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900281-9

7 January 2021

Activation of human T lymphocytes is inhibited by peroxisome proliferator-activated receptor gamma (PPARgamma) agonists. PPARgamma co-association with transcription factor NFAT.

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900281-9

7 January 2021

The effect of gamma-interferon to inhibit macrophage-high density lipoprotein interactions is reversed by 15-deoxy-delta12,14-prostaglandin J2

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900281-9

7 January 2021

Inflammatory mechanisms in Alzheimer's disease: inhibition of beta-amyloid-stimulated proinflammatory responses and neurotoxicity by PPARgamma agonists.

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900281-9

7 January 2021

The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900281-9

7 January 2021

Regulation of ferritin light chain gene expression by oxidized low-density lipoproteins in human monocytic THP-1 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900281-9

7 January 2021

Oxidized LDL reduces monocyte CCR2 expression through pathways involving peroxisome proliferator-activated receptor gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900281-9

7 January 2021

Cyclopentenone prostaglandins: new insights on biological activities and cellular targets

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900281-9

7 January 2021

Inhibition of cellular proliferation through IkappaB kinase-independent and peroxisome proliferator-activated receptor gamma-dependent repression of cyclin D1.

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900281-9

7 January 2021

Expression and function of PPARgamma in rat and human vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900281-9

7 January 2021

Peroxisome proliferator-activated receptor gamma ligands are potent inhibitors of angiogenesis in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900281-9

7 January 2021

Inhibitory effect of prostaglandin delta 12-PGJ2 on cell proliferation and alpha-fetoprotein expression in HuH-7 human hepatoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900281-9

7 January 2021

PGJ2 and delta 12PGJ2 inhibit cell growth accompanied with inhibition of phosphoinositide turnover in human astrocytoma cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900281-9

7 January 2021

15-deoxy-delta12,14-prostaglandin J2, a specific ligand for peroxisome proliferator-activated receptor-gamma, induces neuronal apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900281-9

7 January 2021

Endothelial cell apoptosis induced by the peroxisome proliferator-activated receptor (PPAR) ligand 15-deoxy-Delta12, 14-prostaglandin J2

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900281-9

7 January 2021

Induction of c-fos protooncogene transcription and apoptosis by delta 12-prostaglandin J2 in human Pl-21 myeloid leukemia and RC-K8 pre-B lymphoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900281-9

7 January 2021

Induction of p53 and apoptosis by delta 12-PGJ2 in human hepatocarcinoma SK-HEP-1 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900281-9

7 January 2021

15-Deoxy-Delta(12,14)-prostaglandin J(2), a ligand for peroxisome proliferator-activated receptor-gamma, induces apoptosis in JEG3 choriocarcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900281-9

7 January 2021

Expression of peroxisome proliferator-activated receptors (PPARS) in human astrocytic cells: PPARgamma agonists as inducers of apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900281-9

7 January 2021

15-deoxy-delta(12,14)-PGJ(2) induces synoviocyte apoptosis and suppresses adjuvant-induced arthritis in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900281-9

7 January 2021

Thiazolidinedione induces apoptosis and monocytic differentiation in the promyelocytic leukemia cell line HL60.

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900281-9

7 January 2021

Ligands for peroxisome proliferator-activated receptorgamma and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900281-9

7 January 2021

Influence of J series prostaglandins on apoptosis and tumorigenesis of breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900281-9

7 January 2021

Activation of PPARgamma inhibits cell growth and induces apoptosis in human gastric cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900281-9

7 January 2021

Intracellular glutathione level modulates the induction of apoptosis by delta 12-prostaglandin J2

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900281-9

7 January 2021

Inhibition of human lung cancer cell growth by the peroxisome proliferator-activated receptor-gamma agonists through induction of apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900281-9

7 January 2021

Peroxisome proliferator activator receptor-gamma agonists and 15-deoxy-Delta(12,14)(12,14)-PGJ(2) induce apoptosis in normal and malignant B-lineage cells

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900281-9

7 January 2021

PPARgamma inhibits the expression of c-MET in human gastric cancer cells through the suppression of Ets.

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900281-9

7 January 2021

Activation of PPARgamma leads to inhibition of anchorage-independent growth of human colorectal cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900281-9

7 January 2021

Tumor suppressor and anti-inflammatory actions of PPARgamma agonists are mediated via upregulation of PTEN.

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900281-9

7 January 2021

Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor gamma and the retinoid X receptor.

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900281-9

7 January 2021

Expression of peroxisome proliferator-activated receptor gamma (PPARgamma) in human transitional bladder cancer and its role in inducing cell death

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900281-9

7 January 2021

Peroxisome proliferator-activated receptor gamma ligands inhibit retinoblastoma phosphorylation and G1--> S transition in vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900281-9

7 January 2021

Induction of solid tumor differentiation by the peroxisome proliferator-activated receptor-gamma ligand troglitazone in patients with liposarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900281-9

7 January 2021

Effects of ligand activation of peroxisome proliferator-activated receptor gamma in human prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900281-9

7 January 2021

Prostaglandins up-regulate vascular endothelial growth factor production through distinct pathways in differentiated U937 cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900281-9

7 January 2021

Activators of the nuclear receptor PPARgamma enhance colon polyp formation

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900281-9

7 January 2021

Activation of the peroxisome proliferator-activated receptor γ promotes the development of colon tumors in C57BL/6J-APCMin/+ mice

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900281-9

7 January 2021

A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900281-9

7 January 2021

Activators of peroxisome proliferator-activated receptor gamma have depot-specific effects on human preadipocyte differentiation.

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900281-9

7 January 2021

Fenofibrate and rosiglitazone lower serum triglycerides with opposing effects on body weight

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900281-9

7 January 2021

Glucocorticoids repress induction by thiazolidinediones, fibrates, and fatty acids of phosphoenolpyruvate carboxykinase gene expression in adipocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900281-9

7 January 2021

15-Deoxy-delta(12,14) prostaglandin J2: a putative endogenous promoter of adipogenesis suppresses the ob gene

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900281-9

7 January 2021

PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900281-9

7 January 2021

Binding of prostaglandins to human PPARgamma: tool assessment and new natural ligands

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900281-9

7 January 2021

Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900281-9

7 January 2021

Development of a scintillation proximity assay for peroxisome proliferator-activated receptor gamma ligand binding domain

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900281-9

7 January 2021

A Radioimmunoassay for Prostaglandin A1in Human Peripheral Blood*

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900281-9

7 January 2021

Binding of prostaglandin to human serum albumin

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900281-9

7 January 2021

Albumin regulates induction of peroxisome proliferator-activated receptor-gamma (PPARgamma) by 15-deoxy-delta(12-14)-prostaglandin J(2) in vitro and may be an important regulator of PPARgamma function in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900281-9

7 January 2021

Blood-borne, albumin-bound prostaglandin E2 may be involved in fever.

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900281-9

7 January 2021

Peroxisome proliferator-activated receptor activators target human endothelial cells to inhibit leukocyte-endothelial cell interaction

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900281-9

7 January 2021

Ligand type-specific interactions of peroxisome proliferator-activated receptor gamma with transcriptional coactivators

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900281-9

7 January 2021

Identification and characterization of a prostaglandin transporter

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900281-9

7 January 2021

Cloning, in vitro expression, and tissue distribution of a human prostaglandin transporter cDNA(hPGT)

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900281-9

7 January 2021

Mechanism of prostaglandin E2 transport across the plasma membrane of HeLa cells and Xenopus oocytes expressing the prostaglandin transporter "PGT".

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900281-9

7 January 2021

Molecular identification of a rat novel organic anion transporter moat1, which transports prostaglandin D(2), leukotriene C(4), and taurocholate.

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900281-9

7 January 2021

Human prostaglandin transporter gene (hPGT) is regulated by fluid mechanical stimuli in cultured endothelial cells and expressed in vascular endothelium in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900281-9

7 January 2021

Regulation of adipocyte gene expression by polyunsaturated fatty acids

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900281-9

7 January 2021

Identification of ARA70 as a ligand-enhanced coactivator for the peroxisome proliferator-activated receptor gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900281-9

7 January 2021

15-Deoxy-Delta(12,14)-prostaglandin J(2) facilitates thyroglobulin production by cultured human thyrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900281-9

7 January 2021

15-Deoxy-delta12,14-PGJ2, but not troglitazone, modulates IL-1beta effects in human chondrocytes by inhibiting NF-kappaB and AP-1 activation pathways.

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900281-9

7 January 2021

Characterization of the recombinant human prostanoid DP receptor and identification of L-644,698, a novel selective DP agonist

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900281-9

7 January 2021

A cyclopentenone prostaglandin activates mesangial MAP kinase independently of PPARgamma

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900281-9

7 January 2021

Contribution of cyclopentenone prostaglandins to the resolution of inflammation through the potentiation of apoptosis in activated macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900281-9

7 January 2021

Prostaglandins promote and block adipogenesis through opposing effects on peroxisome proliferator-activated receptor gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900281-9

7 January 2021

15-deoxy-delta 12,14-prostaglandin J2 inhibits multiple steps in the NF-kappa B signaling pathway.

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900281-9

7 January 2021

Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900281-9

7 January 2021

Inhibition of nuclear factor kappa B by prostaglandin A1: an effect associated with heat shock transcription factor activation

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900281-9

7 January 2021

The RxxRxRxxC motif conserved in all Rel/kappa B proteins is essential for the DNA-binding activity and redox regulation of the v-Rel oncoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900281-9

7 January 2021

Peroxisome proliferator-activated receptor gamma ligands suppress the transcriptional activation of cyclooxygenase-2. Evidence for involvement of activator protein-1 and CREB-binding protein/p300.

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900281-9

7 January 2021

A one-vial method for routine extraction and quantification of free fatty acids in blood and tissue by HPLC

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900281-9

7 January 2021

Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900281-9

7 January 2021

Oxidized low density lipoprotein inhibits interleukin-12 production in lipopolysaccharide-activated mouse macrophages via direct interactions between peroxisome proliferator-activated receptor-gamma and nuclear factor-kappa B

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900281-9

7 January 2021

Oxidized LDL regulates vascular endothelial growth factor expression in human macrophages and endothelial cells through activation of peroxisome proliferator-activated receptor-gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900281-9

7 January 2021

Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900281-9

7 January 2021

PPARgamma agonists enhance human vascular endothelial adhesiveness by increasing ICAM-1 expression

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900281-9

7 January 2021

PPARgamma activation in human endothelial cells increases plasminogen activator inhibitor type-1 expression: PPARgamma as a potential mediator in vascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900281-9

7 January 2021

Strong increase in hydroxy fatty acids derived from linoleic acid in human low density lipoproteins of atherosclerotic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900281-9

7 January 2021

Is there a role for 15-lipoxygenase in atherogenesis?

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900281-9

7 January 2021

Expression of the peroxisome proliferator-activated receptor gamma (PPARgamma) in human atherosclerosis and regulation in macrophages by colony stimulating factors and oxidized low density lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900281-9

7 January 2021

Macrophages in human atheroma contain PPARgamma: differentiation-dependent peroxisomal proliferator-activated receptor gamma(PPARgamma) expression and reduction of MMP-9 activity through PPARgamma activation in mononuclear phagocytes in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900281-9

7 January 2021

PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900281-9

7 January 2021

Oxidized phospholipids activate PPARα in a phospholipase A2-dependent manner

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900281-9

7 January 2021

Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900281-9

7 January 2021

Oxidized alkyl phospholipids are specific, high affinity peroxisome proliferator-activated receptor gamma ligands and agonists

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900281-9

7 January 2021

Expression of macrophage (Mphi) scavenger receptor, CD36, in cultured human aortic smooth muscle cells in association with expression of peroxisome proliferator activated receptor-gamma, which regulates gain of Mphi-like phenotype in vitro, and its

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900281-9

7 January 2021

Role for peroxisome proliferator-activated receptor alpha in oxidized phospholipid-induced synthesis of monocyte chemotactic protein-1 and interleukin-8 by endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900281-9

7 January 2021

Inflammatory Platelet-activating Factor-like Phospholipids in Oxidized Low Density Lipoproteins Are Fragmented Alkyl Phosphatidylcholines

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900281-9

7 January 2021

Interleukin-4-dependent production of PPAR-gamma ligands in macrophages by 12/15-lipoxygenase

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900281-9

7 January 2021

Inhibition of mesangial cell nitric oxide in MRL/lpr mice by prostaglandin J2 and proliferator activation receptor-gamma agonists

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900281-9

7 January 2021

A peroxisome proliferator-activated receptor gamma ligand inhibits adipocyte differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900281-9

7 January 2021

Cloning and functional characterization of a novel rat organic anion transporter mediating basolateral uptake of methotrexate in the kidney

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900281-9

7 January 2021

Expression cloning and characterization of a novel multispecific organic anion transporter

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900281-9

7 January 2021

Expression cloning and characterization of ROAT1. The basolateral organic anion transporter in rat kidney

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900281-9

7 January 2021

Molecular cloning and characterization of NKT, a gene product related to the organic cation transporter family that is almost exclusively expressed in the kidney

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900281-9

7 January 2021

Molecular cloning and characterization of multispecific organic anion transporter 4 expressed in the placenta

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900281-9

7 January 2021

Peroxisome proliferator-activated receptors and hepatic stellate cell activation

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900281-9

7 January 2021

15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900281-9

7 January 2021

15-Deoxy-delta(12,14)-prostaglandin J(2) inhibits IL-10 and IL-12 production by macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900281-9

7 January 2021

Suppression of rat thromboxane synthase gene transcription by peroxisome proliferator-activated receptor gamma in macrophages via an interaction with NRF2.

1 reference

https://api.crossref.org/works/10.1016%2FS0898-6568%2801%2900281-9

7 January 2021

10.1016/S0898-6568(01)00281-9

Identifiers

DOI

1 reference

3 August 2017

1 reference

PubMed ID

11955950